274 views | 2 years ago
El Perfil Genómico Integral (PGI) del ADN tumoral circulante (ctDNA) obtenido mediante biopsia líquida sanguínea proporciona resultados importantes para informar la selección de terapias posteriores....
1637 views | 2 years ago
Comprehensive Genomic Profiling (CGP) of circulating tumor DNA (ctDNA) from blood liquid biopsy provides important results to inform subsequent therapy selection. In this video interview, Dr. Atocha...
94718 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
1134 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
381 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
216 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
1090 views | 2 years ago
This video shows the value of connecting your Illumina instrument to Illumina Proactive, a transformative program that brings enhanced service, support, and lab management capabilities to your lab....
1493 views | 2 years ago
During ESMO 2023 in Madrid, Illumina customers speak about the importance of WGS and CGP in their practice. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc...